PRICE T ROWE ASSOCIATES INC /MD/, a registered investment adviser, initiated a new position in AstraZeneca PLC (NASDAQ:AZN) during Q4 2025, according to its most recent 13F filing…
PRICE T ROWE ASSOCIATES INC /MD/, a registered investment adviser, initiated a new position in AstraZeneca PLC (NASDAQ:AZN) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 30,197,350 shares of the Healthcare company, valued at approximately $2.8B as of the filing date.
AstraZeneca PLC's stock currently trades at $204.43 with a market capitalization of $279.9B.
Current market data
NASDAQ · AZN
$165.98
Up: +$1.49 · +0.91%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
institutional ·
institutional ·
dividends ·
institutional ·
